Search Results 321-330 of 3611 for 씨밀레토토

  1. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  2. LS1681: A Study Of AR160 In Treating Patients With Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...

  3. Study Comparing Combination Of LGX818 Plus MEK162 Versus Vemurafenib And LGX818 Monotherapy In BRAF Mutant Melanoma - Mayo Clinic

    LGX818 300mg QD monotherapy (denoted as LGX818 arm) or 3. vemurafenib 960mg BID (denoted as vemurafenib arm) Part 2: Patients will be randomized in a 3:1 ratio ...

  4. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  5. Mayo Clinic Comprehensive Cancer Center Research - Specialized Programs of Research Excellence (SPORE) Grants

    Mayo Clinic Comprehensive Cancer Center has four NCI SPORE grants: Breast cancer, hepatobiliary cancer, multiple myeloma and ovarian cancer.

  6. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...

  7. A Study To Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed And/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - Mayo Clinic

    The goal of this study is to compare how well sonrotoclax plus obinutuzumab works versus venetoclax plus rituximab in treating adults with relapsed and/or ...

  8. Publications

    Publications. Tutty MA, West CP, Dyrbye LN, Wang H, Carlasare LE, Sinsky CA, Trockel M, Shanafelt TD. Moral Distress and Occupational Burnout in US ...

  9. Study Of Imprime PGG And Pembrolizumab In Advanced Melanoma And Triple Negative Breast Cancer - Mayo Clinic

    For the dose that meets the safety criterion in Stage 1, at least 1 response in melanoma subjects and 2 responses in TNBC subjects amongst the 12 subjects ...

  10. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.